117 related articles for article (PubMed ID: 2399194)
1. Treatment of hormone-refractory stage D carcinoma of prostate with coumarin (1,2-benzopyrone) and cimetidine: a pilot study.
Marshall ME; Butler K; Hermansen D
Prostate; 1990; 17(2):95-9. PubMed ID: 2399194
[TBL] [Abstract][Full Text] [Related]
2. Phase I evaluation of coumarin (1,2-benzopyrone) and cimetidine in patients with advanced malignancies.
Marshall ME; Butler K; Fried A
Mol Biother; 1991 Sep; 3(3):170-8. PubMed ID: 1768368
[TBL] [Abstract][Full Text] [Related]
3. Treatment of metastatic renal cell carcinoma with coumarin (1,2-benzopyrone) and cimetidine: a pilot study.
Marshall ME; Mendelsohn L; Butler K; Riley L; Cantrell J; Wiseman C; Taylor R; Macdonald JS
J Clin Oncol; 1987 Jun; 5(6):862-6. PubMed ID: 3585442
[TBL] [Abstract][Full Text] [Related]
4. Treatment of advanced malignant melanoma with coumarin and cimetidine: a pilot study.
Marshall ME; Butler K; Cantrell J; Wiseman C; Mendelsohn L
Cancer Chemother Pharmacol; 1989; 24(1):65-6. PubMed ID: 2720893
[TBL] [Abstract][Full Text] [Related]
5. Effects of coumarin (1,2-benzopyrone) and cimetidine on peripheral blood lymphocytes, natural killer cells, and monocytes in patients with advanced malignancies.
Marshall ME; Riley LK; Rhoades J; Eichhorn T; Jennings CD; Cibull M; Thompson J
J Biol Response Mod; 1989 Feb; 8(1):62-9. PubMed ID: 2921610
[TBL] [Abstract][Full Text] [Related]
6. Phase II evaluation of coumarin (1,2-benzopyrone) in metastatic prostatic carcinoma.
Mohler JL; Gomella LG; Crawford ED; Glode LM; Zippe CD; Fair WR; Marshall ME
Prostate; 1992; 20(2):123-31. PubMed ID: 1549551
[TBL] [Abstract][Full Text] [Related]
7. Coumarin (1,2-benzopyrone) for the treatment of prostatic carcinoma.
Mohler JL; Williams BT; Thompson IM; Marshall ME
J Cancer Res Clin Oncol; 1994; 120 Suppl():S35-8. PubMed ID: 8132702
[TBL] [Abstract][Full Text] [Related]
8. An updated review of the clinical development of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin.
Marshall ME; Mohler JL; Edmonds K; Williams B; Butler K; Ryles M; Weiss L; Urban D; Bueschen A; Markiewicz M
J Cancer Res Clin Oncol; 1994; 120 Suppl():S39-42. PubMed ID: 8132703
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment of advanced malignant melanoma with coumarin and cimetidine. A phase II study.
Pedersen L; Rose C; Langvad E
Cancer Immunol Immunother; 1987; 24(2):178-9. PubMed ID: 3829053
[TBL] [Abstract][Full Text] [Related]
10. Cimetidine and coumarin therapy of renal cell carcinoma. A pilot study.
Kokron O; Maca S; Gasser G; Schmidt PR
Oncology; 1991; 48(2):102-6. PubMed ID: 1997930
[TBL] [Abstract][Full Text] [Related]
11. Combined treatment of advanced malignant melanoma with coumarin and cimetidine.
Nolte H; Pedersen L; Mouridsen HT
Anticancer Res; 1987; 7(3 Pt B):449-50. PubMed ID: 3631904
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the antitumour activity of coumarin in prostate cancer models.
Maucher A; Kager M; von Angerer E
J Cancer Res Clin Oncol; 1993; 119(3):150-4. PubMed ID: 8418087
[TBL] [Abstract][Full Text] [Related]
14. Activity of coumarin and cimetidine in metastatic renal cell carcinoma.
Venook AP; Davenport Y; Tseng A
J Clin Oncol; 1989 Mar; 7(3):402-3. PubMed ID: 2918335
[No Abstract] [Full Text] [Related]
15. Phase II study of coumarin and cimetidine in patients with metastatic renal cell carcinoma.
Dexeus FH; Logothetis CJ; Sella A; Fitz K; Amato R; Reuben JM; Dozier N
J Clin Oncol; 1990 Feb; 8(2):325-9. PubMed ID: 2137163
[TBL] [Abstract][Full Text] [Related]
16. Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases.
Koutsilieris M; Mitsiades CS; Bogdanos J; Dimopoulos T; Karamanolakis D; Milathianakis C; Tsintavis A
Clin Cancer Res; 2004 Jul; 10(13):4398-405. PubMed ID: 15240528
[TBL] [Abstract][Full Text] [Related]
17. 2nd Proceedings of The International Society of Coumarin Investigators (ISCI). 1,2-Benzopyrone (Coumarin): update on mechanisms of action - Treatment of renal cell carcinoma and prostate cancer - Prevention of melanoma recurrence. Hamburg, Germany, 9 March 1994.
J Cancer Res Clin Oncol; 1994; 120 Suppl():S1-42. PubMed ID: 7907598
[No Abstract] [Full Text] [Related]
18. Toxicity of coumarin (1,2-benzopyrone) on human peripheral blood mononuclear cells and human and murine bone marrow progenitor stem cells.
Gallicchio VS; Hulette BC; Harmon C; Marshall ME
J Biol Response Mod; 1989 Apr; 8(2):116-21. PubMed ID: 2732751
[TBL] [Abstract][Full Text] [Related]
19. A phase II trial of carboplatin (NSC 241240) in advanced prostate cancer, refractory to hormonal therapy. An Eastern Cooperative Oncology Group pilot study.
Trump DL; Marsh JC; Kvols LK; Citrin D; Davis TE; Hahn RG; Vogl SE
Invest New Drugs; 1990; 8 Suppl 1():S91-4. PubMed ID: 2199402
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of cimetidine in metastatic melanoma. A Hoosier Oncology Group trial.
Mandanas R; Schultz S; Scullin D; Einhorn LH
Am J Clin Oncol; 1991 Oct; 14(5):397-9. PubMed ID: 1951177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
